Aspen

12/13 Exchange Place , I.F.S.C., Dublin 1, Ireland
Telephone: + 44 1748 828 391
Medical Information Direct Line: 0800 0087 392
Medical Information e-mail: aspenglobal@professionalinformation.co.uk

Patient Information Leaflet last updated on the eMC: 05/05/2011
PIL Zyloric Tablets 100mg, 300mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/05/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
Updated on 15/10/2009 and displayed until 05/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 12/06/2009 and displayed until 15/10/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 29/10/2008 and displayed until 12/06/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 28/09/2006 and displayed until 29/10/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 22/05/2006 and displayed until 28/09/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 05/12/2005 and displayed until 22/05/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 16/01/2004 and displayed until 05/12/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 29/01/2001 and displayed until 16/01/2004
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   allopurinol